Product Information
FOSFOMYCIN 3 GM SACHET is a generic product labeled by Ascend Laboratories, LLC, priced at $26.2204 per EA under NDC 67877074957. Its NADAC has been published 250 times since Dec 22, 2021.
FDA first approved this application on Oct 21, 2021. Its Orange Book therapeutic-equivalence code is AA.
Strength
3 g/1
Manufacturer
Ascend Laboratories, LLCNDC
67877074957
Classification
Generic
Dosage Form
GRANULE, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FOSFOMYCIN TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214554FDA Approved
10/21/2021
TE Code
AA
On Market Since
10/22/2021
Price Statistics
The NADAC for FOSFOMYCIN 3 GM SACHET has been published 250 times since Dec 22, 2021, and over the history we have for it it has declined 62.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.2204 per EA |
|---|---|
| All-time high | $69.8600 (Jan 12, 2022) |
| All-time low | $26.2204 (Sep 23, 2026) |
| 52-week high | $37.0316 |
| 52-week low | $26.2204 |
| Median price | $44.0463 |
| Average price | $46.4062 |
| Largest weekly change | -35.0% (Apr 17, 2024) |
| Weeks tracked | 250 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fosfomycin Tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOSFOMYCIN 3 GM SACHET?
The current National Average Drug Acquisition Cost (NADAC) for FOSFOMYCIN 3 GM SACHET, manufactured by Ascend Laboratories, LLC, is $26.2204 per EA (NDC 67877074957), effective Sep 30, 2026.
How has the price of FOSFOMYCIN 3 GM SACHET changed over time?
Over the history we have for it, the NADAC for FOSFOMYCIN 3 GM SACHET has declined 62.5%. It has been tracked across 250 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for FOSFOMYCIN 3 GM SACHET?
Since Dec 22, 2021, the NADAC for FOSFOMYCIN 3 GM SACHET has ranged from a low of $26.2204 (Sep 23, 2026) to a high of $69.8600 (Jan 12, 2022), with a median of $44.0463 per EA.
Are there cheaper alternatives to FOSFOMYCIN 3 GM SACHET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSFOMYCIN 3 GM SACHET in a comparable dosage form, but none are currently priced below it.
Who manufactures FOSFOMYCIN 3 GM SACHET?
FOSFOMYCIN 3 GM SACHET (NDC 67877074957) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.